Objectives Moderate alcohol consumption is protective against rheumatoid arthritis (RA) development and associated with lower levels of systemic inflammation in RA and in the general population. We therefore hypothesised that moderate alcohol consumption is associated with less severe local inflammation in joints in RA, detected by MRI. Since asymptomatic persons can have low-grade MRI-detected inflammation, we also hypothesised that alcohol consumption is associated with the extent of MRI inflammation in asymptomatic volunteers.
Methods 188 newly presenting patients with RA and 192 asymptomatic volunteers underwent a unilateral contrast-enhanced 1.5T MRI of metacarpophalangeal, wrist and metatarsophalangeal joints. The MRIs were scored on synovitis, bone marrow oedema and tenosynovitis; the sum of these yielded the MRI inflammation score. MRI data were evaluated in relation to current alcohol consumption, categorised as non-drinkers, consuming 1–7 drinks/week, 8–14 drinks/week and >14 drinks/week. Association between C reactive protein (CRP) level and alcohol was studied in 1070 newly presenting patients with RA.
Results Alcohol consumption was not associated with the severity of MRI-detected inflammation in hand and foot joints of patients with RA (P=0.55) and asymptomatic volunteers (P=0.33). A J-shaped curve was observed in the association between alcohol consumption and CRP level, with the lowest levels in patients consuming 1–7 drinks/week (P=0.037).
Conclusion Despite the fact that moderate alcohol consumption has been shown protective against RA, and our data confirm a J-shaped association of alcohol consumption with CRP levels in RA, alcohol was not associated with the severity of joint inflammation. The present data suggest that the pathophysiological mechanism underlying the effect of alcohol consists of a systemic effect that might not involve the joints.
- rheumatoid arthritis
- alcohol consumption
- magnetic resonance imaging
- asymptomatic volunteers
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
- rheumatoid arthritis
- alcohol consumption
- magnetic resonance imaging
- asymptomatic volunteers
What is already known about this subject?
A J-shaped association between alcohol and C reactive protein was confirmed in the present study.
What does this study add?
Alcohol was not associated with the extent of local inflammation in joints.
In the general population moderate alcohol consumption has been associated with lower levels of systemic inflammation, as several studies have shown that alcohol consumption is associated with levels of C reactive protein (CRP) in a J-shaped or U-shaped manner.1 2 Individuals with an alcohol consumption of one to two drinks daily had the lowest CRP levels.
In rheumatoid arthritis (RA), the influence of alcohol consumption on the risk of developing RA has been studied extensively. Moderate alcohol consumption has been associated with a decreased risk of developing RA.3–5 The risk of developing RA was lowest in persons who consumed approximately 1 unit of alcohol per day.3 In patients with RA, alcohol consumption was associated with lower levels of inflammatory markers (eg, CRP and erythrocyte sedimentation rate, soluble tumour necrosis factor receptor II, interleukin-6 (IL-6)).6–8 For IL-6 levels a U-shaped association was also observed, with the lowest IL-6 levels in patients with RA who consumed 1 unit of alcohol per day.6
Within RA the effect of alcohol on local inflammation in joints has been studied once using the swollen joint count (SJC), and no evident association between alcohol consumption and the number of swollen joints was observed in 1238 patients with RA.9 Because MRI is more sensitive than the SJC in detecting local inflammation,10 we anticipated that MRI is useful in detecting an effect of alcohol on the severity of local inflammation in RA.
Furthermore, as the effect of alcohol on markers of systemic inflammation is also present in the general population,1 and since some asymptomatic persons of the general population also have low-graded MRI-detected inflammation,11 12 an association between alcohol and joint inflammation might not be confined to patients with RA, but even be present in asymptomatic volunteers.
Therefore, we hypothesised that moderate alcohol consumption is associated with less inflammation in hand and foot joints, visualised by MRI, both in patients with RA and in asymptomatic volunteers. The present study evaluated these two hypotheses. Furthermore, to validate the previously observed association between alcohol consumption and CRP level in RA, we also studied this association in our cohort of patients with RA.
The patients with RA studied were consecutively included in the Leiden Early Arthritis Clinic (EAC). This is an inception cohort that includes patients with ≥1 swollen joint and a symptom duration of <2 years. When patients presented to the outpatient clinic, questionnaires were obtained that included a self-reported average number of alcohol consumptions per week (current consumption); information on the type of alcohol was not available. Furthermore, physical examination (among which 66 SJC) was performed and blood samples were obtained.13 RA was defined as fulfilling the 1987 American College of Rheumatology criteria during the first year of follow-up. From 1993 to 2016, 1244 patients with RA were included in the EAC cohort. The association between alcohol consumption and CRP was assessed in all patients with RA of whom alcohol consumption was available (1070 patients with RA). From 2010 onwards MRI was added to the study protocol,10 and the association between alcohol and MRI-detected inflammation was assessed in 188 consecutive patients with RA who underwent an MRI at baseline (see online supplementary figure 1 for a flow chart).
The asymptomatic volunteers were recruited between November 2013 and December 2014, and have been described earlier.12 Volunteers were recruited via advertisements on local newspapers and websites. Volunteers had no history of RA or other inflammatory rheumatic diseases, no joint symptoms during the last month and no clinically detectable arthritis at physical examination. Questionnaires were obtained, including self-reported alcohol consumption. CRP levels were not assessed in these volunteers. One hundred and ninety-three volunteers underwent an MRI; in one of these persons, no data on alcohol consumption were obtained. The volunteers received a voucher of €20 to compensate for their time and travel costs and did not receive a report of the MRI. Therefore, volunteers had no/limited benefit from participating.
All participants have given a written informed consent.
MRI protocol and scoring
A contrast-enhanced MRI was performed of the unilateral metacarpophalangeal (MCP) 2–5 joints, wrist joints and metatarsophalangeal (MTP) 1–5 joints. In the EAC the most painful side was scanned, or in case of equally severe symptoms at both sides the dominant side was scanned. In asymptomatic volunteers the dominant side was scanned. All persons were asked to stop non-steroidal anti-inflammatory drugs at least 24 hours prior to the MRI scan. The MRI scans were made prior to the start of disease-modifying antirheumatic drugs (DMARDs) (including corticosteroids). An ONI MSK Extreme 1.5T extremity MRI scanner (GE, milwaukee, Wisconsin, USA) was used. The scan protocol is described in more detail in the online supplementary methods. Briefly, T1-weighted sequences were acquired. After intravenous contrast administration (gadoteric acid, Guerbet, Paris, 0.1 mmol/kg) T1-weighted sequences with fat saturation (T1Gd) were performed. The foot was scanned with T2-weighted fat-saturated (T2) and T1 sequences in the first 106 patients with RA and with T1Gd in the last 82 patients with RA. Scoring of synovitis and bone marrow oedema (BME) was done according to the RA MRI score (RAMRIS) method in the MCP, wrist and MTP joints.14 Tenosynovitis was scored according to Haavardsholm et al 15 in the MCP joints and wrist. The total MRI inflammation score was calculated by summing the synovitis, BME and tenosynovitis scores, and ranged between 0 and 189. MRI scoring was done independently by trained readers; patients with RA were scored by two readers (WPN and ECN), and the asymptomatic volunteers were scored by another two readers (HWvS and LM). Readers were blinded for any clinical data. Furthermore, to exclude observer bias introduced by knowledge that persons had no symptoms, the MRI images of asymptomatic volunteers were mixed with the MRI images of patients with RA and patients with arthralgia without clinical synovitis (n=99). The within-reader intraclass correlation coefficients (ICC) of the readers were all greater than 0.93, and the between-reader ICCs of the four readers were all above 0.91. The mean scores of the two readers were used for the analyses.
Alcohol consumption was categorised into four groups: non-drinkers, participants who consume 1–7 drinks/week, 8–14 drinks/week and >14 drinks/week, and this corresponded to no, one, two and more drinks daily as used in some previous studies.3–6 Groups were compared with the Kruskal-Wallis test and the Mann-Whitney U test when appropriate. The association of alcohol consumption with MRI-detected inflammation was analysed using univariable and multivariable linear regressions adjusted for age, gender, smoking status and anticitrullinated protein antibody (ACPA). ACPA was not assessed in asymptomatic volunteers, and the multivariable linear regression in the asymptomatic volunteers was adjusted for age, gender and smoking status. In the linear regression analyses, MRI inflammation scores were log10-transformed (log10(score +1)) to approximate a normal distribution. To analyse whether a J shape existed in the association between alcohol consumption and CRP levels, a linear regression with a piecewise linear spline on one alcohol consumption per week was used as this fitted the data best. SPSS V.23.0.0 was used for analysis.
Baseline characteristics are presented in table 1. Sixty-four per cent (n=121) of patients with RA who underwent MRI (see online supplementary figure 1 for a flow chart) consumed alcohol at baseline, with a median consumption of 6 drinks/week (IQR 3–11). Of the asymptomatic volunteers, 70% (n=135) consumed alcohol, with a median consumption of 7 drinks/week (IQR 4–14). Patients with RA consumed on average one alcohol consumption less than the asymptomatic volunteers; this difference did not reach statistical significance (P=0.14).
Association of MRI-detected inflammation with alcohol consumption in patients with RA
The extent of MRI-detected inflammation was first compared in four categories of alcohol consumption. The median MRI-detected inflammation in patients with RA did not significantly differ between the four categories: patients with RA who did not drink alcohol had a median MRI inflammation score of 14.8 (IQR=7.0–26.5), patients with RA consuming 1–7 drinks/week had a median of 16.5 (IQR=7.0–27.5), patients with RA consuming 8–14 drinks/week had a median of 16.8 (IQR=8.5–26.5), and patients with RA consuming >14 drinks/week had a median of 15.0 (IQR=12.0–40.5) (P=0.53) (figure 1A). When analysing BME, synovitis and tenosynovitis separately, similar results were seen (see figure 2).
The association between alcohol and MRI-detected inflammation was also evaluated, with the number of alcohol consumptions on a continuous scale also showing no association (β=1.011, 95% CI 0.992 to 1.030, P=0.36). To exclude the possibility of non-significance due to the presence of confounders, the analysis was subsequently adjusted for age, gender, smoking and ACPA. Also, this showed no association between alcohol and inflammation in hand and foot joints (β=0.994, 95% CI 0.975 to 1.013, P=0.53).
Association of MRI-detected inflammation with alcohol consumption in asymptomatic volunteers
In asymptomatic volunteers, the extent of MRI-detected inflammation was also compared in four categories of alcohol consumption. The median MRI-detected inflammation did not significantly differ between the four categories: asymptomatic volunteers who did not drink alcohol had a median MRI inflammation score of 1.5 (IQR=0.5–4.0), 1–7 drinks/week 1.5 (IQR=0.5–4.0), 8–14 drinks/week 2.5 (IQR=1.0–4.0) and >14 drinks/week 3.5 (IQR=1.0–5.0) (P=0.33) (figure 1B). Analysing BME, synovitis and tenosynovitis separately revealed similar results (see figure 3).
Assessing alcohol consumption on a continuous scale, an association was observed in univariable analysis (β=1.018, 95% CI 1.002 to 1.034, P=0.025). However, after adjusting for age, the association disappeared (β=1.003, 95% CI 0.99 to 1.016, P=0.62), and also after adjusting for age, gender and smoking status no association was observed (β=1.002, 95% CI 0.99 to 1.015, P=0.76).
Association of alcohol consumption and CRP in patients with RA
Because of the negative findings done thus far, we searched for a positive control and we wished to verify if the previously observed association between alcohol consumption and CRP was present in our cohort of patients with RA. In a total of 1070 patients with RA, 58% consumed alcohol, with a median consumption of 6 drinks/week (IQR=2–11). The median CRP level in non-drinkers was 16 mg/L (IQR=6–37 mg/L), in patients who consume 1–7 drinks/week the median was 11 mg/L (IQR=5–29 mg/L), in patients who consume 8–14 drinks/week the median was 16 mg/L (IQR=6–31 mg/L), and in patients who consume >14 drinks/week the median was 19 mg/L (IQR=6–41 mg/L). The median CRP levels between these four groups differed significantly (P=0.043). Evaluation by eye suggested the presence of a J-shaped effect, with the lowest CRP in the group that consumes 1–7 drinks/week. Indeed comparing this group with the non-drinkers revealed a significant difference (P=0.011, figure 4). To further confirm this J-shaped effect, a piecewise linear spline regression was used. The regression was divided into two regression coefficients of the J curve (eg, the left decreasing part (compared with no drinks/week), and the right increasing part with the lowest CRP level on 1 drink/week). One drink/week was chosen as this corresponded to the lowest CRP levels. Indeed this piecewise regression showed that CRP level decreased significantly with increasing alcohol consumption up until a maximum of 1 drink/week (β=0.80, 95% CI 0.68 to 0.93, P=0.003). In patients consuming >1 drink/week, CRP levels increased significantly with increasing alcohol consumption (β=1.015, 95% CI 1.004 to 1.025, P=0.006). Hereby, the visually observed J-shaped association was statistically confirmed. In a multivariable analysis adjusting for age, gender, smoking and ACPA status, the downward part of the J curve was still present (β=0.85, 95% CI 0.73 to 0.99, P=0.039), but the upward part of the J curve lost its statistical significance (β=1.007, 95% CI 1.00 to 1.017, P=0.214). A beta of 1.007 indicates that for every drink/week increase in alcohol consumption, there is an 1.007-fold increase in CRP level; thus, in patients consuming >1 drink/week higher alcohol consumption was associated with a higher CRP level.
Finally the number of swollen joints in these patients at disease presentation was studied in relation to alcohol consumption. No association was observed (figure 5).
Moderate alcohol consumption has been associated with less severe systemic inflammation (generally measured using CRP levels) in the general population.1 2 Also within patients with RA, it has been shown repeatedly that moderate alcohol consumption lowers the risk of developing RA and is associated with less severe systemic inflammation.3 4 Because of these findings, we hypothesised that moderate alcohol consumption might also be associated with less severe inflammation in joints, which can be sensitively detected with MRI. The current data revealed no association between alcohol consumption and the severity of local inflammation in hand and foot joints on MRI. Similar to a previous study, we also found no association with the number of swollen joints. Thus, although moderate alcohol consumption is associated with lower levels of systemic inflammation and a lower risk to develop RA, based on the present findings it is not associated with less severe inflammation in joints.
The pathophysiological mechanism underlying the association between alcohol consumption and inflammation is unknown. Different studies explored the immunoregulatory effects of alcohol and various results have been observed. High alcohol consumption has been reported to be associated with depleted cell-mediated and humoral immune responses,16 whereas other data suggest that low alcohol consumption has a stimulatory effect on the cellular immune response.17 Furthermore, higher alcohol consumption was observed to associate with lower levels of tumour necrosis factor receptor II and IL-6,6 whereas moderate alcohol consumption (7–14 units/week) associated with increased levels of IL-2, IL-4 and IL-10, cytokines that are known for anti-inflammatory activities.17 In addition, a U-shaped association between alcohol consumption and IL-6 levels is reported.6 These findings are in line with the observed association between alcohol and the systemic inflammatory marker CRP.
Distinguishing high alcohol consumption from moderate alcohol consumption has several pitfalls. In this study, assessment of alcohol consumption is based on questionnaires and could therefore deviate from the true alcohol consumption. Information on alcohol usage was collected by the number of drinks, assuming common portion sizes: beer (1 glass or bottle), wine (4-ounce glass) and liquor (1 drink or shot). This is similar as done by others, and the alcohol content is estimated to be 10–15 g per drink.18 In addition we did not collect information on the type of alcohol, which is a limitation. Previous large studies have revealed that most persons drink more than one type of alcohol, which makes stratification difficult.1 Furthermore there is controversy on the importance of the type of beverage. Although it has been suggested that the protective effect of alcohol on systemic markers of inflammation is confined to red wine, several studies investigating this issue did not find different effects for different types of alcohol.19–22 Although we cannot make conclusions for different beverages, the fact that the association of alcohol consumption and CRP levels in this study resembles the associations found in the literature1 supports the validity of the data on alcohol consumption.
Alcohol consumption is part of a lifestyle and might therefore be a proxy for other factors associated with lifestyle. So the association of alcohol on joint inflammation might have been influenced by other factors. Multivariate analyses were performed to adjust for some of these factors (among others, age and smoking), but this did not majorly influence the study results.
The lack of association between alcohol consumption and the extent of local joint inflammation on MRI found in this study might have been caused by an inadequate power to detect an effect of alcohol on joint inflammation on MRI, especially as the previously observed effect of alcohol on systemic inflammatory markers, such as CRP levels, was generally observed in very large studies.1 MRI is more time-consuming and more expensive to perform than, for example, CRP level measurements, making an MRI study within thousands of patients with RA infeasible. In our view there was not even a trend towards an association between alcohol and local inflammation; furthermore, in the total group of 1070 patients, alcohol did also not associate with the number of clinically swollen joints. Altogether this makes it unlikely that the present finding is falsely negative.
The present study in early RA had a cross-sectional study design. This allowed us to perform measurements before disease-modifying treatment was initiated. A longitudinal study is needed to evaluate the association between alcohol and long-term outcome of RA, but current treatments and treat-to-target strategies may mask an effect of alcohol (if it is present) on the course of RA.
According to the European Society of Musculoskeletal Radiology recommendations, BME was evaluated on T1Gd. The RAMRIS method suggests to use T2, but T2 was omitted from our scan protocol since previous studies have shown that these sequences perform equally well to depict BME,23 24 and a T1Gd has already been used to assess synovitis and tenosynovitis. This allowed a shorter imaging time for the participants.
Healthy, asymptomatic volunteers can also have some subclinical inflammation in hand and foot joints, especially at older age. The nature of this inflammation is incompletely clear. Immunosenescence or degeneration may play a role. Although the origin is incompletely known, we speculated that a potential effect of alcohol on joint inflammation might also be present in persons without RA. But similar to patients with RA, alcohol did not influence the severity of subclinical inflammation in hand and foot joints of asymptomatic volunteers.
In conclusion, moderate alcohol consumption has been shown to have a beneficial effect on the risk of RA development and inflammatory markers, and the present study confirmed a J-shaped association between alcohol and CRP, and we observed no association between alcohol and the extent of local inflammation in joints. Therefore the present data suggest that the pathophysiological mechanism underlying the effect of alcohol consists of a systemic effect that might not involve the joints.
We acknowledge EC Newsum for scoring the MRIs of the EAC cohort.
Contributors LM, HWvS, WPN, MR and AHMvdH-vM contributed to the conception and design of this study. LM, WPN and HWvS contributed to the acquisition of the data. LM, WPN and AHMvdH-vM analysed and interpreted the data. LM and AHMvdH-vM drafted the manuscript, and WPN, HWvS and MR revised it critically for important intellectual content. All authors approved the final version of the manuscript to be published.
Funding This work was supported by the Dutch Arthritis Foundation and the Netherlands Organisation for Health Research and Development (Vidi grant).
Competing interests None declared.
Patient consent Obtained.
Ethics approval The medical ethics committee of the Leiden University Medical Center approved this study.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.